Global Antifungal infection Therapeutics Market Size, Status and Forecast 2020-2026

Published On: Mar 2020

Format: PDF

Publisher: QY Research

Pages: 134

Report ID: 421790

This report focuses on the global Antifungal infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antifungal infection Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories

Market segment by Type, the product can be split into
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types
Market segment by Application, split into
Powders
Pastes
Ointments
Drugs
Other Applications

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antifungal infection Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Antifungal infection Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Antifungal infection Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antifungal infection Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Polyenes
1.4.3 Echinocandins
1.4.4 Azoles
1.4.5 Allylamines
1.4.6 Other Drug types
1.5 Market by Application
1.5.1 Global Antifungal infection Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Powders
1.5.3 Pastes
1.5.4 Ointments
1.5.5 Drugs
1.5.6 Other Applications
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Antifungal infection Therapeutics Market Perspective (2015-2026)
2.2 Antifungal infection Therapeutics Growth Trends by Regions
2.2.1 Antifungal infection Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antifungal infection Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Antifungal infection Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Antifungal infection Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Antifungal infection Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Antifungal infection Therapeutics Players by Market Size
3.1.1 Global Top Antifungal infection Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antifungal infection Therapeutics Market Concentration Ratio
3.2.1 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Antifungal infection Therapeutics Revenue in 2019
3.3 Antifungal infection Therapeutics Key Players Head office and Area Served
3.4 Key Players Antifungal infection Therapeutics Product Solution and Service
3.5 Date of Enter into Antifungal infection Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2021-2026)

5 Antifungal infection Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Antifungal infection Therapeutics Market Size by Application (2015-2020)
5.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Antifungal infection Therapeutics Market Size (2015-2020)
6.2 Antifungal infection Therapeutics Key Players in North America (2019-2020)
6.3 North America Antifungal infection Therapeutics Market Size by Type (2015-2020)
6.4 North America Antifungal infection Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Antifungal infection Therapeutics Market Size (2015-2020)
7.2 Antifungal infection Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Antifungal infection Therapeutics Market Size by Type (2015-2020)
7.4 Europe Antifungal infection Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Antifungal infection Therapeutics Market Size (2015-2020)
8.2 Antifungal infection Therapeutics Key Players in China (2019-2020)
8.3 China Antifungal infection Therapeutics Market Size by Type (2015-2020)
8.4 China Antifungal infection Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Antifungal infection Therapeutics Market Size (2015-2020)
9.2 Antifungal infection Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Antifungal infection Therapeutics Market Size by Type (2015-2020)
9.4 Japan Antifungal infection Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Antifungal infection Therapeutics Market Size (2015-2020)
10.2 Antifungal infection Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antifungal infection Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Antifungal infection Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Antifungal infection Therapeutics Market Size (2015-2020)
11.2 Antifungal infection Therapeutics Key Players in India (2019-2020)
11.3 India Antifungal infection Therapeutics Market Size by Type (2015-2020)
11.4 India Antifungal infection Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Antifungal infection Therapeutics Market Size (2015-2020)
12.2 Antifungal infection Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Antifungal infection Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Antifungal infection Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Scynexis
13.1.1 Scynexis Company Details
13.1.2 Scynexis Business Overview and Its Total Revenue
13.1.3 Scynexis Antifungal infection Therapeutics Introduction
13.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2015-2020))
13.1.5 Scynexis Recent Development
13.2 Sanofi-Aventis
13.2.1 Sanofi-Aventis Company Details
13.2.2 Sanofi-Aventis Business Overview and Its Total Revenue
13.2.3 Sanofi-Aventis Antifungal infection Therapeutics Introduction
13.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.2.5 Sanofi-Aventis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Antifungal infection Therapeutics Introduction
13.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis Antifungal infection Therapeutics Introduction
13.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Merck & Co
13.5.1 Merck & Co Company Details
13.5.2 Merck & Co Business Overview and Its Total Revenue
13.5.3 Merck & Co Antifungal infection Therapeutics Introduction
13.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.5.5 Merck & Co Recent Development
13.6 Kramer Laboratories
13.6.1 Kramer Laboratories Company Details
13.6.2 Kramer Laboratories Business Overview and Its Total Revenue
13.6.3 Kramer Laboratories Antifungal infection Therapeutics Introduction
13.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.6.5 Kramer Laboratories Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview and Its Total Revenue
13.7.3 Johnson & Johnson Antifungal infection Therapeutics Introduction
13.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 ID Sigma-Aldrich Corporation
13.8.1 ID Sigma-Aldrich Corporation Company Details
13.8.2 ID Sigma-Aldrich Corporation Business Overview and Its Total Revenue
13.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Introduction
13.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.8.5 ID Sigma-Aldrich Corporation Recent Development
13.9 Glenmark Pharmaceuticals
13.9.1 Glenmark Pharmaceuticals Company Details
13.9.2 Glenmark Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Introduction
13.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.9.5 Glenmark Pharmaceuticals Recent Development
13.10 Glaxosmithkline
13.10.1 Glaxosmithkline Company Details
13.10.2 Glaxosmithkline Business Overview and Its Total Revenue
13.10.3 Glaxosmithkline Antifungal infection Therapeutics Introduction
13.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2015-2020)
13.10.5 Glaxosmithkline Recent Development
13.11 Enzon Pharmaceuticals
10.11.1 Enzon Pharmaceuticals Company Details
10.11.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue
10.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Introduction
10.11.4 Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2015-2020)
10.11.5 Enzon Pharmaceuticals Recent Development
13.12 Bayer Healthcare
10.12.1 Bayer Healthcare Company Details
10.12.2 Bayer Healthcare Business Overview and Its Total Revenue
10.12.3 Bayer Healthcare Antifungal infection Therapeutics Introduction
10.12.4 Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2015-2020)
10.12.5 Bayer Healthcare Recent Development
13.13 Astellas Pharma
10.13.1 Astellas Pharma Company Details
10.13.2 Astellas Pharma Business Overview and Its Total Revenue
10.13.3 Astellas Pharma Antifungal infection Therapeutics Introduction
10.13.4 Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2015-2020)
10.13.5 Astellas Pharma Recent Development
13.14 Asperqillus
10.14.1 Asperqillus Company Details
10.14.2 Asperqillus Business Overview and Its Total Revenue
10.14.3 Asperqillus Antifungal infection Therapeutics Introduction
10.14.4 Asperqillus Revenue in Antifungal infection Therapeutics Business (2015-2020)
10.14.5 Asperqillus Recent Development
13.15 Alternaria
10.15.1 Alternaria Company Details
10.15.2 Alternaria Business Overview and Its Total Revenue
10.15.3 Alternaria Antifungal infection Therapeutics Introduction
10.15.4 Alternaria Revenue in Antifungal infection Therapeutics Business (2015-2020)
10.15.5 Alternaria Recent Development
13.16 Abbott Laboratories
10.16.1 Abbott Laboratories Company Details
10.16.2 Abbott Laboratories Business Overview and Its Total Revenue
10.16.3 Abbott Laboratories Antifungal infection Therapeutics Introduction
10.16.4 Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2015-2020)
10.16.5 Abbott Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details